On March 17, Swiss HeiQ Innovative Textile Technology Company (HeiQ), which has repeatedly won the Swiss Technology Award and the Swiss Environmental Protection Award, announced the successful test of anti-viral and anti-bacterial textile treatment technology HeiQ Viroblock NPJ03 in Zurich, Switzerland. It has a significant effect against coronavirus.
HeiQ is a company focusing on textile technology innovation. For 15 years, HeiQ has helped More than a hundred well-known brands improve the functionality of textiles. To support the global fight against coronavirus, HeiQ has timely launched its antiviral and antibacterial textile treatment technology HeiQ Viroblock NPJ03 (“Viroblock”). Mask tests have proven effective against human coronaviruses. Masks treated with Viroblock significantly reduce the infectivity of human coronavirus (229E), influenza viruses H1N1, H5N1, H7N9 and respiratory syncytial virus (RSV). Among them, in the test against human coronavirus, the logarithmic reduction value of the viral infectivity of the untreated mask was 2.90, while the logarithmic reduction value of the mask treated with Viroblock increased to 4.48, and the viral infectivity was reduced by more than 99.99%.
Carlo Centonze, CEO of HeiQ Group, said: “HeiQ Scientific Consulting The committee’s virologist, Dr. Thierry Pelet, brings a wealth of knowledge that accelerates our efforts to address the pressing global pandemic. Our goal is to prevent textiles from becoming host surfaces for the spread of harmful viruses and bacteria, and to Contribute to reducing the risk and speed of contamination and transmission.”
The World Health Organization says the incubation period of the new coronavirus is 1 to 14 days. Wearing a mask is a common measure taken by most people in Asia to avoid the spread of the virus. Chinese protective mask manufacturer Suzhou Bolisi Medical Technology Co., Ltd. (Bolisi) is the first to adopt Viroblock, and the treated masks will be available as early as April this year. American tights and socks manufacturer Kayser-Roth plans to add this technology to their new products. in the product. Many international textile manufacturers, such as China’s Lufeng Textile and Dyeing Co., Ltd., are evaluating the use of Viroblock in other types of fabrics for clothing. Dr. Pellet said: “I am deeply impressed by HeiQ’s ability to quickly track such a complex innovation and bring this breakthrough to a globally critical product in a short period of time.”
According to reports, Viroblock uniquely combines vesicle and silver technology to inhibit the growth and retention of bacteria and viruses. HeiQ vesicle technology targets lipid-developed viruses such as coronaviruses and quickly kills them, while HeiQ silver technology inhibits the replication of bacteria and viruses. Viroblock can be used on a variety of textile surfaces, including masks, air filters, medical gowns, curtains, and more. So far, scientists have identified seven human coronaviruses. 229E and Covid-19 are two of them.
<br
